- Home
- RVSN vs ADAP Comparison
RVSN vs ADAP Comparison
Compare RVSN & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- ADAP
- Stock Information
- Founded
- RVSN 2016
- ADAP 2008
- Country
- RVSN Israel
- ADAP United Kingdom
- Employees
- RVSN N/A
- ADAP N/A
- Industry
- RVSN
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- ADAP Health Care
- Exchange
- RVSN Nasdaq
- ADAP Nasdaq
- Market Cap
- RVSN 24.0M
- ADAP 21.3M
- IPO Year
- RVSN 2022
- ADAP 2015
- Fundamental
- Price
- RVSN $0.54
- ADAP $0.06
- Analyst Decision
- RVSN
- ADAP Hold
- Analyst Count
- RVSN 0
- ADAP 6
- Target Price
- RVSN N/A
- ADAP $1.02
- AVG Volume (30 Days)
- RVSN 14.6M
- ADAP 126.7M
- Earning Date
- RVSN 08-22-2025
- ADAP 11-12-2025
- Dividend Yield
- RVSN N/A
- ADAP N/A
- EPS Growth
- RVSN N/A
- ADAP N/A
- EPS
- RVSN N/A
- ADAP N/A
- Revenue
- RVSN $776,000.00
- ADAP $65,084,999.00
- Revenue This Year
- RVSN $1,861.54
- ADAP N/A
- Revenue Next Year
- RVSN N/A
- ADAP $24.70
- P/E Ratio
- RVSN N/A
- ADAP N/A
- Revenue Growth
- RVSN N/A
- ADAP N/A
- 52 Week Low
- RVSN $0.27
- ADAP $0.04
- 52 Week High
- RVSN $2.72
- ADAP $0.86
- Technical
- Relative Strength Index (RSI)
- RVSN 52.80
- ADAP 39.51
- Support Level
- RVSN $0.46
- ADAP $0.04
- Resistance Level
- RVSN $0.56
- ADAP $0.09
- Average True Range (ATR)
- RVSN 0.11
- ADAP 0.03
- MACD
- RVSN -0.01
- ADAP -0.02
- Stochastic Oscillator
- RVSN 17.42
- ADAP 10.04
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.